Last reviewed · How we verify
NCT06163794: MetabotypAGE
New Participatory Research Strategy and Multidimensional Phenotyping Towards Personalized Preventive Nutritional Support for Elderly People
NA trial testing Nutritional postprandial test in Non Dependant 60 to 75 Year-old Men and Women in 250 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 250 |
| Start date | 14 February 2024 |
| Primary completion | 30 June 2026 |
| Estimated completion | 1 March 2027 |
| Sites | 3 locations across France |
Drugs / interventions tested
- Nutritional postprandial test
Conditions studied
- Non Dependant 60 to 75 Year-old Men and Women — all drugs for Non Dependant 60 to 75 Year-old Men and Women →
Sponsor
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Who can join
Adults 60 to 75, any sex, with Non Dependant 60 to 75 Year-old Men and Women. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Characterize the inter-individual variability of the blood glucose postprandial response
Time frame: Within the first month of study realization
Kinetics of change in postprandial blood glucose over a period of 4 hours following home consumption of four types of test meals by continuously monitoring blood glucose
Sponsor's own description
There is high inter-individual variability in the response to feeding, which is determined by multiple interacting factors such as age, sex, genotype, gut microbiota, eating behaviors, physical activity or even socio-demographic factors. Original studies have recently demonstrated the possibility of predicting the postprandial response to the diet of healthy individuals on the basis of in-depth phenotyping, and of offering them foods adapted to their own metabolic capacities according to their belonging to different groups of individuals defined on the basis of the similarity of their metabolic capacities. Due to different life trajectories, inter-individual variability could be amplified upon entry into the aging period, which could explain at least in part why traditional strategies for managing chronic age-related pathologies are insufficient. The investigators aim is to propose a new strategy to better understand inter-individual variability in the response to food in the elderly based on deep phenotyping.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Body Composition and Senescence: Impact of Polyphenols on Aging-Associated Events.
Santos TWD, Pereira QC, Fortunato IM, Oliveira FS, et al · · 2024 · cited 4× · PMID 39519454 · DOI 10.3390/nu16213621
Verify or expand the search:
- PubMed search for NCT06163794
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement trials
Trials by the same sponsor.
- NCT07521189 — Effect of Vegetarien Diet on Protein Digestibility in Young and Elderly Volunteers · NA · recruiting
- NCT07212400 — Collection of Stool From Healthy Donors for the ex Vivo Study of Shifts of Microbiome Induced by Dairy Phages and Antibi · recruiting
- NCT07162025 — Improving Nutrition for Babies Born by Caesarean Section · recruiting
- NCT06174233 — The French Gut-colo · recruiting
- NCT06436937 — Protein Quality of Fava Bean and Honey Chlorella in Humans · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06163794 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
- Last refreshed: 24 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06163794.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing